Chronic Bronchiolitis or Resistant Asthma?

Sponsor
Baqiyatallah Medical Sciences University (Other)
Overall Status
Completed
CT.gov ID
NCT00368342
Collaborator
(none)

Study Details

Study Description

Brief Summary

Chronic Bronchiolitis or Resistant Asthma? Testing a way to diagnosis and treatment

Condition or Disease Intervention/Treatment Phase
  • Drug: Erythromycin, Azithromycin , Clarithromycin
Phase 4

Study Design

Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Difficult asthma
    Exclusion Criteria:
    • Patients with potential allergic bronchopulmonary aspergillosis i.e. with peripheral blood eosinophilia, sputum eosinophilia, or any sputum production and bronchiectasis

    • A history of smoking

    • Significant occupational or environmental exposures

    • Evidence on emphysema on chest high resolution computed tomography (HRCT) scan

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Baqiyatallah Medical Sciences University

    Investigators

    • Principal Investigator: Mostafa Ghanei, Prof, Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00368342
    Other Study ID Numbers:
    • S-340-14-6-1-PU-79
    First Posted:
    Aug 24, 2006
    Last Update Posted:
    Feb 19, 2009
    Last Verified:
    Jan 1, 2006

    Study Results

    No Results Posted as of Feb 19, 2009